Gastrointestinal Systems Market Share

North American Market Forecast

The gastrointestinal radiofrequency ablation systems market in North America is projected to hold the largest share of 35% by the end of 2036. The growth of the market can be attributed majorly to the increasing incidence of stomach cancer. There may be a growing demand for therapeutic options, such as RFA, as more cases of stomach cancer are discovered in the region. For instance, in some instances, gastrointestinal RFA may be a good alternative to surgery for the treatment of early-stage stomach cancer. Further, the presence of a strong healthcare network in the region, along with the growing usage of gastrointestinal radiofrequency ablation, is also anticipated to contribute to the market growth in the region.

APAC Market Statistics

The Asia Pacific gastrointestinal radiofrequency ablation systems market is estimated to be the second largest share of 28% by the end of 2036. The growth of the market can be attributed majorly to the improving healthcare system. Access to healthcare is one of the main advantages of improved healthcare systems for people in the region. This may lead to earlier diagnosis of gastrointestinal diseases, such as stomach cancer, and raise demand for RFA systems. In addition, funding for medical research and development may rise in the area as a result of improved healthcare systems. This may result in the development of fresh and ground-breaking medical innovations, such as improvements in gastrointestinal RFA. Further, the increasing prevalence of cancer in the region, along with the growing awareness about gastrointestinal radiofrequency ablation, are also anticipated to contribute to the market growth in the region.